L&C Bio Co. Ltd (290650) — Capital Reinvestment Ratio
Latest as of September 2025:
0.82x
L&C Bio Co. Ltd (290650) has a Capital Reinvestment Ratio of 0.82x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩3.79 Billion) in capital expenditures (₩3.10 Billion). See L&C Bio Co. Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.82x
Capex / Operating Cash Flow
Operating Cash Flow
₩3.79 Billion
KRW
Capital Expenditures
₩3.10 Billion
KRW
Data as of
Sep 2025
Most recent filing
L&C Bio Co. Ltd Capital Reinvestment Ratio (2017–2021)
This chart tracks L&C Bio Co. Ltd's Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for L&C Bio Co. Ltd (2017–2021)
Year-by-year Capital Reinvestment Ratio for L&C Bio Co. Ltd from 2017 to 2021. For live market cap and broader valuation context, see L&C Bio Co. Ltd (290650) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.94x | ₩10.91 Billion | ₩10.25 Billion | ▲ +131.2% |
| 2020 | 0.41x | ₩7.42 Billion | ₩3.02 Billion | ▲ +33.6% |
| 2019 | 0.30x | ₩6.43 Billion | ₩1.96 Billion | ▼ -75.3% |
| 2018 | 1.23x | ₩3.85 Billion | ₩4.74 Billion | ▲ +1548.9% |
| 2017 | 0.07x | ₩3.82 Billion | ₩285.34 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow